These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31650785)

  • 1. New epigenomic and genomic frontiers in personalized medicine: direct customer testing, are we ready?
    Dolcini J; Knox J; Baccarelli A
    Epidemiol Prev; 2019; 43(4):295-299. PubMed ID: 31650785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in trauma: a transformational frontier in patient care, education, and research.
    Davis CS; Wilkinson KH; Lin E; Carpenter NJ; Georgeades C; Lomberk G; Urrutia R
    Eur J Trauma Emerg Surg; 2022 Aug; 48(4):2607-2612. PubMed ID: 34786598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine--a tailored health care system: challenges and opportunities.
    Louca S
    Croat Med J; 2012 Jun; 53(3):211-3. PubMed ID: 22661133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct to consumer genetic testing-law and policy concerns in Ireland.
    de Paor A
    Ir J Med Sci; 2018 Aug; 187(3):575-584. PubMed ID: 29177916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease.
    Strianese O; Rizzo F; Ciccarelli M; Galasso G; D'Agostino Y; Salvati A; Del Giudice C; Tesorio P; Rusciano MR
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of genetic tests in the era of personalized medicine].
    Molnár JM; Magyarósi S; Németh G
    Magy Onkol; 2013 Mar; 57(1):16-20. PubMed ID: 23573517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment.
    Najafzadeh M; Lynd LD; Davis JC; Bryan S; Anis A; Marra M; Marra CA
    Genet Med; 2012 May; 14(5):520-6. PubMed ID: 22241089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health genomics and personalized prevention: lessons from the COGS project.
    Pashayan N; Hall A; Chowdhury S; Dent T; Pharoah PD; Burton H
    J Intern Med; 2013 Nov; 274(5):451-6. PubMed ID: 24127941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should direct-to-consumer personalized genomic medicine remain unregulated?: a rebuttal of the defenses.
    Valles SA
    Perspect Biol Med; 2012; 55(2):250-65. PubMed ID: 22643762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the development of personalized genomic medicine and surgery.
    Brunicardi FC; Gibbs RA; Wheeler DA; Nemunaitis J; Fisher W; Goss J; Chen C
    World J Surg; 2011 Aug; 35(8):1693-9. PubMed ID: 21424870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal genomics in Greece: an overview of available direct-to-consumer genomic services and the relevant legal framework.
    Kechagia S; Mai Y; Vidalis T; Patrinos GP; Vayena E
    Public Health Genomics; 2014; 17(5-6):299-305. PubMed ID: 25278084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
    Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.
    Mathews R; Hall W; Carter A
    Addiction; 2012 Dec; 107(12):2069-74. PubMed ID: 22510165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-consumer genetic testing: a systematic review of european guidelines, recommendations, and position statements.
    Rafiq M; Ianuale C; Ricciardi W; Boccia S
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):535-47. PubMed ID: 26313927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human genomics projects and precision medicine.
    Carrasco-Ramiro F; Peiró-Pastor R; Aguado B
    Gene Ther; 2017 Sep; 24(9):551-561. PubMed ID: 28805797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic gatekeepers: regulating direct-to-consumer genomic services in an era of participatory medicine.
    Palmer JE
    Food Drug Law J; 2012; 67(4):475-524, iii. PubMed ID: 24640618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics for disease treatment and prevention.
    Bloss CS; Jeste DV; Schork NJ
    Psychiatr Clin North Am; 2011 Mar; 34(1):147-66. PubMed ID: 21333845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Medicine and Medicinal Chemistry: Toward a Legal Framework in the European Union.
    Duardo-Sánchez A; De Miguel Beriain I
    Curr Top Med Chem; 2018; 18(25):2165-2173. PubMed ID: 30465506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.